The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Cefazolin Loaded Oxidized Regenerated Cellulose/Polycaprolactone Bilayered Composite for Use as Potential Antibacterial Dural Substitute
Abstract
Oxidized regenerated cellulose/polycaprolactone bilayered composite (ORC/PCL bilayered composite) was investigated for use as an antibacterial dural substitute. Cefazolin at the concentrations of 25, 50, 75 and 100 mg/mL was loaded in the ORC/PCL bilayered composite. Microstructure, density, thickness, tensile properties, cefazolin loading content, cefazolin releasing profile and antibacterial activity against S. aureus were measured. It was seen that the change in concentration of cefazolin loading affected the microstructure of the composite on the rough side, but not on the dense or smooth side. Cefazolin loaded ORC/PCL bilayered composite showed greater densities, but lower thickness, compared to those of drug unloaded composite. Tensile modulus was found to be greater and increased with increasing cefazolin loading, but tensile strength and strain at break were lower compared to the drug unloaded composite. In vitro cefazolin release in artificial cerebrospinal fluid (aCSF) consisted of initial burst release on day 1, followed by a constant small release of cefazolin. The antibacterial activity was observed to last for up to 4 days depending on the cefazolin loading. All these results suggested that ORC/PCL bilayered composite could be modified to serve as an antibiotic carrier for potential use as an antibacterial synthetic dura mater.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Infection control following craniocerebral surgery is a key factor that affects prognosis (Sanpakitwattana et al., 2022).”
From Complex bioactive nanofibrous dura mater repairs traumatic brain injury (2026) · cites this paper as Sanpakitwattana et al., 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug/device combinations for local drug therapies and infection prophylaxis
Wu, P., & Grainger, D. W. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.11.031 · Cited by 491
Therapeutic applications of implantable drug delivery systems
Dash, A., & Cudworth, G. (1998) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(98)00027-6 · Cited by 358
Research works printed but not linked: 49
- Wang, 2019, Research and application progress on dural substitutes, J. Neurorestoratol., 7, 161, 10.26599/JNR.2019.9040020 · DOI
- Choi, 2021, Effectiveness of repair techniques for spinal dural tears: A systematic review, World Neurosurg., 149, 140, 10.1016/j.wneu.2021.02.079 · doi:10.1016/j.wneu.2021.02.079
- Suwanprateeb, 2016, Bilayer oxidized regenerated cellulose/poly ε-caprolactone knitted fabric-reinforced composite for use as an artificial dural substitute, J. Mater. Sci. Mater. Med., 27, 122, 10.1007/s10856-016-5736-z · DOI
- Hemstapat, 2020, Performance evaluation of bilayer oxidized regenerated cellulose/poly ε-caprolactone knitted fabric reinforced composites for dural substitution, Proc. Inst. Mech. Eng. Part H J. Eng. Med., 234, 854, 10.1177/0954411920926071 · doi:10.1177/0954411920926071
- Chumnanvej, 2020, In vivo evaluation of bilayer ORC/PCL composites in a rabbit model for using as a dural substitute, Neurol. Res., 42, 879, 10.1080/01616412.2020.1789383 · DOI
- Dwivedi, 2020, Polycaprolactone as biomaterial for bone scaffolds: Review of literature, J. Oral Biol. Craniofac. Res., 10, 381, 10.1016/j.jobcr.2019.10.003 · DOI · Paper page
- Backes, 2022, Polycaprolactone usage in additive manufacturing strategies for tissue engineering applications: A review, J. Biomed. Mater. Res. B Appl. Biomater., 110, 1479, 10.1002/jbm.b.34997 · DOI
- Kleine, J., Leisz, S., Ghadban, C., Hohmann, T., Prell, J., Scheller, C., Strauss, C., Simmermacher, S., and Dehghani, F. (2021). Variants of oxidized regenerated cellulose and their distinct effects on neuronal tissue. Int. J. Mol. Sci., 22. · DOI
- Bassetti, 2015, Antimicrobial prophylaxis in minor and major surgery, Minerva Anestesiol., 81, 76
- Erman, 2005, Risk factors for surgical site infections in neurosurgery patients with antibiotic prophylaxis, Surg. Neurol., 63, 107, 10.1016/j.surneu.2004.04.024 · DOI
- Bratzler, 2013, Clinical practice guidelines for antimicrobial prophylaxis in surgery, Am. J. Health Syst. Pharm., 70, 195, 10.2146/ajhp120568 · DOI · Paper page
- Liu, 2014, Antibiotic prophylaxis in craniotomy: A review, Neurosurg. Rev., 37, 407, 10.1007/s10143-014-0524-z · doi:10.1007/s10143-014-0524-z
- Gyssens, 1999, Preventing postoperative infections: Current treatment recommendations, Drugs, 57, 175, 10.2165/00003495-199957020-00004 · doi:10.2165/00003495-199957020-00004
- Brocard, 2021, Antibiotic prophylaxis for surgical procedures: A scoping review, Rev. Panam. Salud. Publica, 45, e62, 10.26633/RPSP.2021.62 · DOI
- Kusaba, 2009, Safety and efficacy of cefazolin sodium in the management of bacterial infection and in surgical prophylaxis, Clin. Med. Ther., 1, 1607
- Wassif, 2021, Recent advances in the local antibiotics delivery systems for management of osteomyelitis, Drug Deliv., 28, 2392, 10.1080/10717544.2021.1998246 · DOI
- Stebbins, 2014, Antibiotic-containing polymers for localized, sustained drug delivery, Adv. Drug Deliv. Rev., 78, 77, 10.1016/j.addr.2014.04.006 · DOI
- Mutsuzaki, 2014, Cefazolin-containing poly(ε-caprolactone) sponge pad to reduce pin tract infection rate in rabbits. Asia-Pac, J. Sports Med. Arthrosc. Rehabil. Technol., 1, 54
- Radisavljevic, 2018, Cefazolin-loaded polycaprolactone fibers produced via different electrospinning methods: Characterization, drug release and antibacterial effect, Eur. J. Pharm. Sci., 124, 26, 10.1016/j.ejps.2018.08.023 · DOI
- Lee, J.H., Park, J.K., Son, K.H., and Lee, J.W. (2022). PCL/sodium-alginate based 3D-printed dual drug delivery system with antibacterial activity for osteomyelitis therapy. Gels, 8. · doi:10.3390/gels8030163
- Yazdi, 2014, Cefazolin-loaded mesoporous silicon microparticles show sustained bactericidal effect against Staphylococcus aureus, J. Tissue Eng., 5, 2041731414536573, 10.1177/2041731414536573 · DOI
- Munir, 2019, Controllably biodegradable hydroxyapatite nanostructures for cefazolin delivery against antibacterial aesistance, ACS Omega, 4, 7524, 10.1021/acsomega.9b00541 · DOI
- Rath, 2016, Fabrication and characterization of cefazolin-loaded nanofibrous mats for the recovery of post-surgical wound, Artif. Cells Nanomed. Biotechnol., 44, 1783, 10.3109/21691401.2015.1102741 · doi:10.3109/21691401.2015.1102741
- Rath, 2016, Development and characterization of cefazolin loaded zinc oxide nanoparticles composite gelatin nanofiber mats for postoperative surgical wounds, Mater. Sci. Eng. C, 58, 242, 10.1016/j.msec.2015.08.050 · DOI
- Wang, 2013, Preliminary exploration of the development of a collagenous artificial dura mater for sustained antibiotic release, Chin. Med. J., 126, 3329, 10.3760/cma.j.issn.0366-6999.20130618 · doi:10.3760/cma.j.issn.0366-6999.20130618
- Kaplan, 2011, Use of antibiotic-impregnated DuraGen ® to reduce the risk of infection in dura repair: An in vitro study, Cen. Eur. Neurosurg., 72, 75, 10.1055/s-0030-1267246 · doi:10.1055/s-0030-1267246
- Suwanprateeb, 2014, Preparation and characterizations of antibiotic impregnated microporous nano-hydroxyapatite for osteomyelitis treatment, Biomed. Eng. Appl. Basis Commun., 26, 1450041, 10.4015/S1016237214500410 · doi:10.4015/s1016237214500410
- Guillen, 2011, Preparation and characterization of membranes formed by nonsolvent induced phase separation: A review, Ind. Eng. Chem. Res., 50, 3798, 10.1021/ie101928r · DOI · Paper page
- Tan, X.M., and Rodrigue, D. (2019). A review on porous polymeric membrane preparation. Part I: Production techniques with polysulfone and poly (vinylidene fluoride). Polymers, 11. · doi:10.3390/polym11071160
- Dijkstra, 1996, Phase separation processes in polymer solutions in relation to membrane formation, J. Membr. Sci., 117, 1, 10.1016/0376-7388(96)00088-9 · DOI · Paper page
- Bashkatov, 2003, Glucose and mannitol diffusion in human dura mater, Biophys. J., 85, 3310, 10.1016/S0006-3495(03)74750-X · DOI · Paper page
- Black, 1981, A study of the uniaxial mechanical properties of human dura mater preserved in glycerol, Biomaterials, 2, 41, 10.1016/0142-9612(81)90086-7 · DOI
- Opálková Šišková, A., Bucková, M., Kroneková, Z., Kleinová, A., Nagy, Š., Rydz, J., Opálek, A., Sláviková, M., and Eckstein Andicsová, A. (2021). The drug-loaded electrospun poly(ε-caprolactone) mats for therapeutic application. Nanomaterials, 11. · DOI
- Gao, 2021, Mechanical properties and drug loading rate of a polycaprolactone 5-fluorouracil controlled drug delivery system, Mater. Res. Express, 8, 095302, 10.1088/2053-1591/ac1fb5 · DOI
- Glover, K., Mathew, E., Pitzanti, G., Magee, E., and Lamprou, D. (2022). 3D bioprinted scaffolds for diabetic wound healing applications. Drug Deliv. Transl. Res. · DOI
- Rychter, 2018, Cilostazol-loaded poly(ε-caprolactone) electrospun drug delivery System for cardiovascular applications, Pharm. Res., 35, 32, 10.1007/s11095-017-2314-0 · DOI
- Martin, 1981, The mechanical properties of human dura mater and the effects of storage media, Clin. Phys. Physiol. Meas., 2, 197, 10.1088/0143-0815/2/3/003 · doi:10.1088/0143-0815/2/3/003
- Zarzur, 1996, Mechanical properties of the human lumbar dura mater, Arq. Neuropsiquiatr., 54, 455, 10.1590/S0004-282X1996000300015 · DOI
- Kamaraj, 2017, Fabrication, characterization, in vitro drug release and glucose uptake activity of 14-deoxy, 11, 12-didehydroandrographolide loaded polycaprolactone nanoparticles, Asian J. Pharm. Sci., 12, 353, 10.1016/j.ajps.2017.02.003 · DOI
- Yoo, 2020, Phenomenology of the initial burst release of drugs from PLGA microparticles, ACS Biomater. Sci. Eng., 6, 6053, 10.1021/acsbiomaterials.0c01228 · DOI · Paper page
- Hu, 2014, Electrospinning of polymeric nanofibers for drug delivery applications, J. Control. Release, 185, 12, 10.1016/j.jconrel.2014.04.018 · DOI · Paper page
- Karuppuswamy, 2015, Polycaprolactone nanofibers for the controlled release of tetracycline hydrochloride, Mater. Lett., 141, 180, 10.1016/j.matlet.2014.11.044 · DOI
- Liu, 2018, Polycaprolactone nanofibres loaded with 20(S)-protopanaxadiol for in vitro and in vivo anti-tumour activity study, R. Soc. Open Sci., 5, 180137, 10.1098/rsos.180137 · DOI
- Frantz, 1943, Absorbable Cotton, Paper and Gauze: (Oxidized Cellulose), Ann. Surg., 118, 116, 10.1097/00000658-194311810-00010 · doi:10.1097/00000658-194311810-00010
- Spangler, 2003, In Vitro Antimicrobial Activity of Oxidized Regenerated Cellulose against Antibiotic-Resistant Microorganisms, Surg. Infect., 4, 255, 10.1089/109629603322419599 · DOI
- Huang, 2001, On the importance and mechanisms of burst release in matrix-controlled drug delivery systems, J. Control. Release, 73, 121, 10.1016/S0168-3659(01)00248-6 · DOI · Paper page
- Page, 1993, Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care, Arch. Surg., 128, 79, 10.1001/archsurg.1993.01420130087014 · doi:10.1001/archsurg.1993.01420130087014
- Patel, 2019, Risk factors for surgical site infections in neurosurgery, Ann. R. Coll. Surg. Engl., 101, 220, 10.1308/rcsann.2019.0001 · doi:10.1308/rcsann.2019.0001
- Mindermann, 2021, Empirically adapted or personalized antibiotic prophylaxis in select cranial neurosurgery?, Acta Neurochir., 163, 365, 10.1007/s00701-020-04558-5 · doi:10.1007/s00701-020-04558-5
Cited by
Complex bioactive nanofibrous dura mater repairs traumatic brain injury
Chen, S., Zhang, X., Guo, Q., Yan, Y., Fu, M., Wang, Y., & Wu, T. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00621 · Cited by 3
Metadata
- Authors
- Sanpakitwattana, A., Suvannapruk, W., Chumnanvej, S., Hemstapat, R., & Suwanprateeb, J.
- Affiliations
- Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
- Biofunctional Materials and Devices Research Group, National Metal and Materials Technology Center (MTEC), Pathum Thani 12120, Thailand
- Neurosurgical Unit, Surgery Department, Faculty of Medicine Ramathibodi Hospital, Bangkok 10400, Thailand
- Venue
- Polymers
- Publisher
- MDPI AG
- Published
- 2022-10-21
- Volume
- 14
- Issue
- 20
- Pages
- 4449
- ISSN
- 2073-4360
- Cited by
- 17
- References
- 2
- Language
- en
- Funders
- Science Achievement Scholarship of Thailand
- Faculty of Science and the Faculty of Medicine Ramathibodi Hospital, Mahidol University
- National Metal and Materials Technology Center (MTEC)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.